ESTHER
CONDE GALLEGO
Profesora asociada de Ciencias de la Salud
Fundación Jiménez Díaz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (8)
2024
-
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach
Archives of pathology & laboratory medicine, Vol. 148, Núm. 3, pp. 318-326
-
RET Fusion Testing in Patients With NSCLC: The RETING Study
JTO Clinical and Research Reports, Vol. 5, Núm. 4
-
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer
Clinical Cancer Research, Vol. 30, Núm. 14, pp. 3036-3049
2022
-
Clinical and economic impact of ‘ROS1-testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain
BMC Cancer, Vol. 22, Núm. 1
-
Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing
Journal of Clinical Pathology, Vol. 75, Núm. 3, pp. 145-153
2021
-
Targeted therapy moves to earlier stages of non-small-cell lung cancer: Emerging evidence, controversies and future challenges
Future Oncology, Vol. 17, Núm. 30, pp. 4011-4025
2020
-
Immunotherapy moves to the early-stage setting in non-small cell lung cancer: Emerging evidence and the role of biomarkers
Cancers, Vol. 12, Núm. 11, pp. 1-21
2011
-
Composite anatomical-clinical-molecular prognostic model in nonsmall cell lung cancer
European Respiratory Journal, Vol. 37, Núm. 1, pp. 136-142